[BusinessWire] — QurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS)

alps adria conference on dementia :: dementia news :: [businesswire] — quralis raises $42 million series a financing to develop new therapies for amyotrophic lateral sclerosis (als)

Funding led by Polaris Partners, Mission BioCapital, INKEF Capital and the Dementia Discovery Fund

QurAlis intends to use this funding to support the development of new therapies for amyotrophic lateral sclerosis (ALS) and genetically related frontotemporal dementia (FTD), neurodegenerative diseases for which there is currently no cure.

More >>

Leave a Reply